Key Events This Week
May 11: Stock surges 5.39% despite Sensex fall
May 12: Rating upgraded to Hold by MarketsMOJO
May 13: Technical momentum shifts to mildly bullish
May 15: Week closes with a 1.17% gain amid mixed market
Jun 08, 03:30 PM
BSE+NSE Vol: 17.22 k

Suraksha Diagnostic Ltd, a micro-cap player in the Healthcare Services sector, has experienced a subtle shift in price momentum, moving from a sideways trend to a mildly bearish stance. Despite some bullish weekly technical indicators, the overall technical landscape presents a complex picture, with key metrics such as moving averages and volume-based indicators signalling caution for investors.
Read full news article
Suraksha Diagnostic Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 June 2026, providing investors with the most up-to-date view of the company’s performance and outlook.
Read full news article
Suraksha Diagnostic Ltd, a micro-cap player in the Healthcare Services sector, has experienced a subtle shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend on weekly charts. Despite a recent upgrade in technical outlook, the company’s overall MarketsMOJO grade has been downgraded from Hold to Sell, reflecting cautious sentiment amid mixed indicator signals and modest price gains.
Read full news article
Suraksha Diagnostic Ltd, a micro-cap player in the Healthcare Services sector, has experienced a subtle shift in its technical momentum, moving from a mildly bullish to a mildly bearish trend. Despite some positive weekly indicators, the overall technical landscape suggests caution for investors as the stock price declined by 1.45% on 2 June 2026, closing at ₹281.20.
Read full news article
Suraksha Diagnostic Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, reflecting a potential recalibration of investor sentiment amid evolving market dynamics. Despite a recent minor dip in share price, the company’s valuation metrics relative to peers and historical averages suggest a more compelling investment case within the healthcare services sector.
Read full news article
Suraksha Diagnostic Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 May 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the company’s current position as of 24 May 2026, providing investors with the latest insights into the stock’s performance and outlook.
Read full news articleSuraksha Diagnostic Ltd's latest financial results for the quarter ended March 2026 present a mixed picture. The company achieved net sales of ₹81.41 crores, marking a sequential growth of 4.79% and a year-on-year increase of 25.07%. This growth reflects a strong demand for diagnostic services and effective market penetration, as net sales have consistently risen over the past five quarters. However, profitability metrics indicate significant challenges. The company's net profit for the quarter was ₹6.28 crores, which represents a decline of 16.49% compared to the previous quarter and 15.02% year-on-year. Additionally, the operating profit margin, excluding other income, decreased to 29.93% from 30.62% in the prior quarter, suggesting pressures from rising costs and potentially pricing challenges. The PAT margin also contracted to 7.57%, down from 9.32%, indicating a deterioration in operational efficiency...
Read full news article
Suraksha Diagnostic Ltd., a Kolkata-based healthcare services provider with a market capitalisation of ₹1,537 crores, reported consolidated net profit of ₹6.28 crores for Q4 FY26, marking a sharp decline of 16.49% quarter-on-quarter and 15.02% year-on-year. The results underscore mounting profitability challenges despite sustained revenue expansion, with the stock declining 4.05% following the announcement to close at ₹307.00 on May 22, 2026.
Read full news article